{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:30:07Z","timestamp":1792024207101,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670566"],"award-info":[{"award-number":["81670566"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872359"],"award-info":[{"award-number":["81872359"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["021414380449"],"award-info":[{"award-number":["021414380449"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ischemia reperfusion injury (IRI) has been shown to increase the risk of tumor recurrence after liver surgery. Also, nonalcoholic fatty liver disease (NAFLD) is associated with increased HCC recurrence. ALOX12\u201312-HETE pathway is activated both in liver IRI and NASH. Also, ALOX12\u201312-HETE has been shown to mediate tumorigenesis and progression. Therefore, our study aims to investigate whether the ALOX12\u201312-HETE-GPR31 pathway involved in IRI induced HCC recurrence in NAFLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>HCC mouse model was used to mimic the HCC recurrence in NAFLD. Western Blot, qPCR, Elisa and Immunofluorescence analysis were conducted to evaluate the changes of multiple signaling pathways during HCC recurrence, including ALOX12\u201312-HETE axis, EMT, MMPs and PI3K\/AKT\/NF-\u03baB signaling pathway. We also measured the expression and functional changes of GPR31 by siRNA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>ALOX12\u201312-HETE pathway was activated in liver IRI and its activation was further enhanced in NAFLD, which induced more severe HCC recurrence in fatty livers than normal livers. Inhibition of ALOX12\u201312-HETE by ML355 reduced the HCC recurrence in fatty livers. In vitro studies showed that 12-HETE increased the expression of GPR31 and induced epithelial-mesenchymal transition (EMT) and matrix metalloprotein (MMPs) by activating PI3K\/AKT\/NF-\u03baB pathway. Furthermore, knockdown of GPR31 in cancer cells inhibited the HCC recurrence in NAFLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>ALOX12\u201312-HETE-GPR31 played an important role in HCC recurrence and might be a potential therapeutic target to reduce HCC recurrence after surgery in fatty livers.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13046-019-1480-9","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T09:21:31Z","timestamp":1576228891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Ischemia reperfusion injury promotes recurrence of hepatocellular carcinoma in fatty liver via ALOX12-12HETE-GPR31 signaling axis"],"prefix":"10.1186","volume":"38","author":[{"given":"Faji","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longcheng","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"issue":"2","key":"1480_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/gutjnl-2017-315068","volume":"67","author":"A Gerbes","year":"2018","unstructured":"Gerbes A, Zoulim F, Tilg H, Dufour JF, Bruix J, Paradis V, Salem R, Peck-Radosavljevic M, Galle PR, Greten TF, et al. Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. Gut. 2018;67(2):380\u20138.","journal-title":"Gut."},{"issue":"6","key":"1480_CR2","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1002\/hep.26986","volume":"59","author":"RJ Wong","year":"2014","unstructured":"Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology. 2014;59(6):2188\u201395.","journal-title":"Hepatology."},{"issue":"6","key":"1480_CR3","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/hep.1840360609","volume":"36","author":"JA Marrero","year":"2002","unstructured":"Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 2002;36(6):1349\u201354.","journal-title":"Hepatology."},{"issue":"5","key":"1480_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.21037\/hbsn.2018.08.01","volume":"7","author":"T Wen","year":"2018","unstructured":"Wen T, Jin C, Facciorusso A, Donadon M, Han HS, Mao Y, Dai C, Cheng S, Zhang B, Peng B, et al. Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus. Hepatobiliary Surg Nutr. 2018;7(5):353\u201371.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"1480_CR5","doi-asserted-by":"crossref","unstructured":"Citores MJ, Lucena JL, de la Fuente S, Cuervas-Mons V. serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation. World J Hepatol 2019; 11(1):50\u201364.","DOI":"10.4254\/wjh.v11.i1.50"},{"key":"1480_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.metabol.2018.03.023","volume":"85","author":"T Zhang","year":"2018","unstructured":"Zhang T, Zhao X, Steer CJ, Yan G, Song G. A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet. Metabolism. 2018;85:183\u201391.","journal-title":"Metabolism."},{"issue":"4","key":"1480_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/bjs.10080","volume":"103","author":"LA Orci","year":"2016","unstructured":"Orci LA, Lacotte S, Oldani G, Slits F, De Vito C, Crowe LA, Rubbia-Brandt L, Vallee JP, Morel P, Toso C. Effect of ischaemic preconditioning on recurrence of hepatocellular carcinoma in an experimental model of liver steatosis. Br J Surg. 2016;103(4):417\u201326.","journal-title":"Br J Surg"},{"issue":"1","key":"1480_CR8","doi-asserted-by":"publisher","first-page":"8935","DOI":"10.1038\/s41598-018-27319-y","volume":"8","author":"M Gr\u0105t","year":"2018","unstructured":"Gr\u0105t M, Krawczyk M, Wronka KM, Stypu\u0142kowski J, Lewandowski Z, Wasilewicz M, Krawczyk P, Gr\u0105t K, Patkowski W, Zieniewicz K. Ischemia-reperfusion injury and the risk of hepatocellular carcinoma recurrence after deceased donor liver transplantation. Sci Rep. 2018;8(1):8935.","journal-title":"Sci Rep"},{"key":"1480_CR9","doi-asserted-by":"crossref","unstructured":"Orci LA, Lacotte S, Delaune V, Slits F, Oldani G, Lazarevic V, Rossetti C, Rubbia-Brandt L, Morel P, Toso C. Effects of the gut-liver axis on ischemia-mediated hepatocellular carcinoma recurrence in the mouse liver. J Hepatol. 2018.","DOI":"10.26226\/morressier.5a38ffa2d462b8029238b56c"},{"issue":"2","key":"1480_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/lt.24042","volume":"21","author":"PA Vagefi","year":"2015","unstructured":"Vagefi PA, Dodge JL, Yao FY, Roberts JP. Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl. 2015;21(2):187\u201394.","journal-title":"Liver Transpl"},{"issue":"51","key":"1480_CR11","doi-asserted-by":"crossref","first-page":"88918","DOI":"10.18632\/oncotarget.21493","volume":"8","author":"S Wang","year":"2017","unstructured":"Wang S, Yang FJ, Wang X, Zhou Y, Dai B, Han B, Ma HC, Ding YT, Shi XL. PARP-1 promotes tumor recurrence after warm ischemic liver graft transplantation via neutrophil recruitment and polarization. Oncotarget. 2017;8(51):88918\u201333.","journal-title":"Oncotarget."},{"key":"1480_CR12","doi-asserted-by":"crossref","unstructured":"Mashima R, Okuyama T. The role of lipoxygenases in pathophysiology; new insights and future perspectives. Redox biology. 2015; 6(undefined):297\u2013310.","DOI":"10.1016\/j.redox.2015.08.006"},{"issue":"1","key":"1480_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1172\/JCI61453","volume":"122","author":"D Wang","year":"2012","unstructured":"Wang D, Dubois RN. Epoxyeicosatrienoic acids: a double-edged sword in cardiovascular diseases and cancer. J Clin Invest. 2012;122(1):19\u201322.","journal-title":"J Clin Invest"},{"issue":"1","key":"1480_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nm.4451","volume":"24","author":"XJ Zhang","year":"2018","unstructured":"Zhang XJ, Cheng X, Yan ZZ, Fang J, Wang X, Wang W, Liu ZY, Shen LJ, Zhang P, Wang PX, et al. An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury. Nat Med. 2018;24(1):73\u201383.","journal-title":"Nat Med"},{"key":"1480_CR15","doi-asserted-by":"crossref","unstructured":"Tanaka N, Matsubara T, Krausz KW, Patterson AD, Gonzalez FJ. Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology (Baltimore, Md). 2012; 56(1):118\u2013129.","DOI":"10.1002\/hep.25630"},{"key":"1480_CR16","doi-asserted-by":"crossref","unstructured":"Nie D. Cyclooxygenases and lipoxygenases in prostate and breast cancers. Frontiers in bioscience : a journal and virtual library. 2007; 12(undefined):1574\u20131585.","DOI":"10.2741\/2170"},{"issue":"6","key":"1480_CR17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1593\/neo.04286","volume":"6","author":"UP Kelavkar","year":"2004","unstructured":"Kelavkar UP, Glasgow W, Olson SJ, Foster BA, Shappell SB. Overexpression of 12\/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice. Neoplasia. 2004;6(6):821\u201330.","journal-title":"Neoplasia."},{"issue":"5","key":"1480_CR18","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1172\/JCI44751","volume":"121","author":"D Kerjaschki","year":"2011","unstructured":"Kerjaschki D, Bago-Horvath Z, Rudas M, Sexl V, Schneckenleithner C, Wolbank S, Bartel G, Krieger S, Kalt R, Hantusch B, et al. Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J Clin Invest. 2011;121(5):2000\u201312.","journal-title":"J Clin Invest"},{"issue":"44","key":"1480_CR19","doi-asserted-by":"publisher","first-page":"17991","DOI":"10.1073\/pnas.1106499108","volume":"108","author":"JR Beach","year":"2011","unstructured":"Beach JR, Hussey GS, Miller TE, Chaudhury A, Patel P, Monslow J, Zheng Q, Keri RA, Reizes O, Bresnick AR, et al. Myosin II isoform switching mediates invasiveness after TGF-beta-induced epithelial-mesenchymal transition. Proc Natl Acad Sci U S A. 2011;108(44):17991\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1480_CR20","doi-asserted-by":"crossref","unstructured":"Ou H, Chen Z, Xiang L, Fang Y, Xu Y, Liu Q, Hu Z, Li X, Huang Y, Yang D. Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma. Cancer science. 2019; undefined (undefined):undefined.","DOI":"10.1111\/cas.13949"},{"key":"1480_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.matbio.2015.01.004","volume":"44-46","author":"S Duarte","year":"2015","unstructured":"Duarte S, Baber J, Fujii T, Coito AJ. Matrix metalloproteinases in liver injury, repair and fibrosis. Matrix Biol. 2015;44-46:147\u201356.","journal-title":"Matrix Biol"},{"key":"1480_CR22","doi-asserted-by":"crossref","unstructured":"Bj\u00f6rklund M, Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 2005; 1755(1):37\u201369.","DOI":"10.1016\/j.bbcan.2005.03.001"},{"key":"1480_CR23","doi-asserted-by":"crossref","unstructured":"Rong W, Zhang Y, Yang L, Feng L, Wei B, Wu F, Wang L, Gao Y, Cheng S, Wu J, Xiao T. Post-surgical resection prognostic value of combined OPN, MMP7, and PSG9 plasma biomarkers in hepatocellular carcinoma. Frontiers of medicine. 2018; undefined (undefined):undefined.","DOI":"10.1007\/s11684-018-0632-1"},{"key":"1480_CR24","doi-asserted-by":"crossref","unstructured":"Liu X, Feng M, Zhang Y, Dai C, Sun B, Bao X, Deng K, Yao Y, Wang R. Expression of Matrix Metalloproteinase-9, Pituitary Tumor Transforming Gene, High Mobility Group A 2, and Ki-67 in Adrenocorticotropic Hormone-Secreting Pituitary Tumors and Their Association with Tumor Recurrence. World neurosurgery. 2018; 113(undefined):e213-e221.","DOI":"10.1016\/j.wneu.2018.01.214"},{"key":"1480_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.freeradbiomed.2018.06.043","volume":"124","author":"F Yang","year":"2018","unstructured":"Yang F, Wang S, Liu Y, Zhou Y, Shang L, Feng M, Yuan X, Zhu W, Shi X. IRE1alpha aggravates ischemia reperfusion injury of fatty liver by regulating phenotypic transformation of kupffer cells. Free Radic Biol Med. 2018;124:395\u2013407.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"1480_CR26","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/hep.27358","volume":"61","author":"S Nagai","year":"2015","unstructured":"Nagai S, Yoshida A, Facciuto M, Moonka D, Abouljoud MS, Schwartz ME, Florman SS. Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation. Hepatology. 2015;61(3):895\u2013904.","journal-title":"Hepatology."},{"issue":"10","key":"1480_CR27","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/bjs.9868","volume":"102","author":"LA Orci","year":"2015","unstructured":"Orci LA, Berney T, Majno PE, Lacotte S, Oldani G, Morel P, Mentha G, Toso C. Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation. Br J Surg. 2015;102(10):1250\u20137.","journal-title":"Br J Surg"},{"issue":"9","key":"1480_CR28","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/apt.13380","volume":"42","author":"A Kornberg","year":"2015","unstructured":"Kornberg A, Witt U, Kornberg J, Friess H, Thrum K. Treating ischaemia-reperfusion injury with prostaglandin E1 reduces the risk of early hepatocellular carcinoma recurrence following liver transplantation. Aliment Pharmacol Ther. 2015;42(9):1101\u201310.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"1480_CR29","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/SLA.0b013e3182a6183e","volume":"258","author":"L Vigano","year":"2013","unstructured":"Vigano L, Capussotti L, De Rosa G, De Saussure WO, Mentha G, Rubbia-Brandt L. Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival. Ann Surg. 2013;258(5):731\u201340 discussion 741-732.","journal-title":"Ann Surg"},{"issue":"6","key":"1480_CR30","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/bjs.9057","volume":"100","author":"ZZ Hamady","year":"2013","unstructured":"Hamady ZZ, Rees M, Welsh FK, Toogood GJ, Prasad KR, John TK, Lodge JP. Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases. Br J Surg. 2013;100(6):820\u20136.","journal-title":"Br J Surg"},{"issue":"5","key":"1480_CR31","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1245\/s10434-007-9758-0","volume":"15","author":"JD van der Bilt","year":"2008","unstructured":"van der Bilt JD, Kranenburg O, Borren A, van Hillegersberg R, Borel Rinkes IH. Ageing and hepatic steatosis exacerbate ischemia\/reperfusion-accelerated outgrowth of colorectal micrometastases. Ann Surg Oncol. 2008;15(5):1392\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"1480_CR32","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1477-2574.2012.00602.x","volume":"15","author":"A Mathur","year":"2013","unstructured":"Mathur A, Franco ES, Leone JP, Osman-Mohamed H, Rojas H, Kemmer N, Neff GW, Rosemurgy AS, Alsina AE. Obesity portends increased morbidity and earlier recurrence following liver transplantation for hepatocellular carcinoma. HPB (Oxford). 2013;15(7):504\u201310.","journal-title":"HPB (Oxford)"},{"issue":"7","key":"1480_CR33","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1016\/j.transproceed.2016.08.020","volume":"48","author":"P Taura","year":"2016","unstructured":"Taura P, Martinez-Palli G, Blasi A, Rivas E, Beltran J, Balust J. Intraoperative Management of High-Risk Liver Transplant Recipients: concerns and challenges. Transplant Proc. 2016;48(7):2491\u20134.","journal-title":"Transplant Proc"},{"issue":"1","key":"1480_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2017","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2017;15(1):11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"1480_CR35","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/nm.2507","volume":"17","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig HK, Eckle T. Ischemia and reperfusion--from mechanism to translation. Nat Med. 2011;17(11):1391\u2013401.","journal-title":"Nat Med"},{"issue":"1","key":"1480_CR36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/nm.4468","volume":"24","author":"SP Monga","year":"2018","unstructured":"Monga SP. Lipid metabolic reprogramming in hepatic ischemia\u2013reperfusion injury. Nat Med. 2018;24(1):6\u20137.","journal-title":"Nat Med"},{"issue":"4","key":"1480_CR37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bbalip.2016.07.014","volume":"1862","author":"JA Ackermann","year":"2017","unstructured":"Ackermann JA, Hofheinz K, Zaiss MM, Kronke G. The double-edged role of 12\/15-lipoxygenase during inflammation and immunity. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862(4):371\u201381.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"9","key":"1480_CR38","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/liv.12541","volume":"34","author":"AI Fitian","year":"2014","unstructured":"Fitian AI, Nelson DR, Liu C, Xu Y, Ararat M, Cabrera R. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC\/MS and UPLC\/MS-MS. Liver Int. 2014;34(9):1428\u201344.","journal-title":"Liver Int"},{"issue":"3","key":"1480_CR39","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/bjc.2016.201","volume":"115","author":"CH Nguyen","year":"2016","unstructured":"Nguyen CH, Stadler S, Brenner S, Huttary N, Krieger S, Jager W, Dolznig H, Krupitza G. Cancer cell-derived 12(S)-HETE signals via 12-HETE receptor, RHO, ROCK and MLC2 to induce lymph endothelial barrier breaching. Br J Cancer. 2016;115(3):364\u201370.","journal-title":"Br J Cancer"},{"issue":"12","key":"1480_CR40","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nrd4390","volume":"13","author":"RE Vandenbroucke","year":"2014","unstructured":"Vandenbroucke RE, Libert C. Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat Rev Drug Discov. 2014;13(12):904\u201327.","journal-title":"Nat Rev Drug Discov"},{"key":"1480_CR41","doi-asserted-by":"crossref","unstructured":"Escaff S, Fernandez JM, Gonzalez LO, Su\u00e1rez A, Gonzalez-Reyes S, Gonzalez JM, Vizoso FJ. Study of matrix metalloproteinases and their inhibitors in prostate cancer. Br J Cancer 2010; 102(5):922\u2013929.","DOI":"10.1038\/sj.bjc.6605569"},{"key":"1480_CR42","doi-asserted-by":"crossref","unstructured":"Koskensalo S, Louhimo J, Nordling S, Hagstr\u00f6m J, Haglund C. MMP-7 as a prognostic marker in colorectal cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2011; 32(2):259\u2013264.","DOI":"10.1007\/s13277-010-0080-2"},{"key":"1480_CR43","doi-asserted-by":"crossref","unstructured":"Liu Y, Zhang X, Zhou S, Shi J, Xu Y, He J, Lin F, Wei A, Zhou L, Chen Z. Knockdown of Golgi phosphoprotein 73 blocks the trafficking of matrix metalloproteinase-2 in hepatocellular carcinoma cells and inhibits cell invasion. Journal of cellular and molecular medicine. 2019; undefined (undefined):undefined.","DOI":"10.1111\/jcmm.14055"},{"key":"1480_CR44","doi-asserted-by":"crossref","unstructured":"Chen R, Cui J, Xu C, Xue T, Guo K, Gao D, Liu Y, Ye S, Ren Z. The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection. Annals of surgical oncology. 2012; null (undefined):S375\u2013384.","DOI":"10.1245\/s10434-011-1836-7"},{"key":"1480_CR45","doi-asserted-by":"crossref","unstructured":"Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016; 166(1):21\u201345.","DOI":"10.1016\/j.cell.2016.06.028"},{"key":"1480_CR46","doi-asserted-by":"crossref","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA. epithelial-mesenchymal transitions in development and disease. Cell. 2009; 139(5):871\u2013890.","DOI":"10.1016\/j.cell.2009.11.007"},{"key":"1480_CR47","doi-asserted-by":"crossref","unstructured":"Ye X, Tam WL, Shibue T, Kaygusuz Y, Reinhardt F, Eaton EN, Weinberg RA. Distinct EMT programs control normal mammary stem cells and tumour-initiating cells. Nature. 2015; 525(7568):256\u2013260.","DOI":"10.1038\/nature14897"},{"key":"1480_CR48","doi-asserted-by":"crossref","unstructured":"Tang Y, Wang R, Zhang Y, Lin S, Qiao N, Sun Z, Cheng S, Zhou W. Co-Upregulation of 14\u20133-3\u03b6 and P-Akt is Associated with Oncogenesis and Recurrence of Hepatocellular Carcinoma. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 2018; 45(3):1097\u20131107.","DOI":"10.1159\/000487351"},{"key":"1480_CR49","doi-asserted-by":"crossref","unstructured":"Guo Y, Zhang W, Giroux C, Cai Y, Ekambaram P, Dilly AK, Hsu A, Zhou S, Maddipati KR, Liu J, Joshi S, et al. Identification of the orphan G protein-coupled receptor GPR31 as a receptor for 12-(S)-hydroxyeicosatetraenoic acid. J Biol Chem 2011; 286(39):33832\u201333840.","DOI":"10.1074\/jbc.M110.216564"},{"key":"1480_CR50","doi-asserted-by":"crossref","unstructured":"Honn KV, Guo Y, Cai Y, Lee MJ, Dyson G, Zhang W, Tucker SC. 12-HETER1\/GPR31, a high-affinity 12(S)-hydroxyeicosatetraenoic acid receptor, is significantly up-regulated in prostate cancer and plays a critical role in prostate cancer progression. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2016; 30(6):2360\u20132369.","DOI":"10.1096\/fj.201500076"},{"issue":"23","key":"1480_CR51","doi-asserted-by":"publisher","first-page":"11089","DOI":"10.1158\/0008-5472.CAN-06-2407","volume":"66","author":"RN Kaplan","year":"2006","unstructured":"Kaplan RN, Rafii S, Lyden D. Preparing the \"soil\": the premetastatic niche. Cancer Res. 2006;66(23):11089\u201393.","journal-title":"Cancer Res"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1480-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-019-1480-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1480-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:50:49Z","timestamp":1607647849000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-019-1480-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1480"],"URL":"https:\/\/doi.org\/10.1186\/s13046-019-1480-9","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"20 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal experiments were approved by the Institutional Animal Care and Use Committee of Nanjing University, China, based on the NIH Guide for the Care and Use of Laboratory Animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"489"}}